[go: up one dir, main page]

NO962320L - Tricykliske 5,6-dihydro-9H-pyrazolo [3,4cÅ-1,2,4-triazolo [4,3-aÅ pyridiner - Google Patents

Tricykliske 5,6-dihydro-9H-pyrazolo [3,4cÅ-1,2,4-triazolo [4,3-aÅ pyridiner

Info

Publication number
NO962320L
NO962320L NO962320A NO962320A NO962320L NO 962320 L NO962320 L NO 962320L NO 962320 A NO962320 A NO 962320A NO 962320 A NO962320 A NO 962320A NO 962320 L NO962320 L NO 962320L
Authority
NO
Norway
Prior art keywords
triazolo
pyrazolo
tricyclic
dihydro
pyridine
Prior art date
Application number
NO962320A
Other languages
English (en)
Other versions
NO306256B1 (no
NO962320D0 (no
Inventor
Allen Jacob Duplantier
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO962320D0 publication Critical patent/NO962320D0/no
Publication of NO962320L publication Critical patent/NO962320L/no
Publication of NO306256B1 publication Critical patent/NO306256B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO962320A 1995-06-06 1996-06-05 Tricykliske 5,6-dihydro-9H-pyrazolo [3,4c]-1,2,4-triazolo [4,3-a]pyridiner, anvendelse derav og farmasöytisk preparat NO306256B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002223624A CA2223624C (en) 1995-06-06 1995-06-06 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
PCT/IB1995/000429 WO1996039408A1 (en) 1995-06-06 1995-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
HU9601541A HUP9601541A3 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO962320D0 NO962320D0 (no) 1996-06-05
NO962320L true NO962320L (no) 1996-12-09
NO306256B1 NO306256B1 (no) 1999-10-11

Family

ID=89994031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962320A NO306256B1 (no) 1995-06-06 1996-06-05 Tricykliske 5,6-dihydro-9H-pyrazolo [3,4c]-1,2,4-triazolo [4,3-a]pyridiner, anvendelse derav og farmasöytisk preparat

Country Status (43)

Country Link
US (1) US6004974A (no)
EP (1) EP0837860B1 (no)
JP (1) JP3107827B2 (no)
KR (2) KR100191972B1 (no)
CN (1) CN1061044C (no)
AP (1) AP609A (no)
AR (1) AR002745A1 (no)
AT (1) ATE214700T1 (no)
AU (1) AU694871B2 (no)
BG (1) BG62568B1 (no)
BR (1) BR9602627A (no)
CA (1) CA2223624C (no)
CO (1) CO4700460A1 (no)
CZ (1) CZ287251B6 (no)
DE (1) DE69525978T2 (no)
DK (1) DK0837860T3 (no)
DZ (1) DZ2044A1 (no)
ES (1) ES2172583T3 (no)
FI (1) FI114097B (no)
HR (1) HRP960268B1 (no)
HU (1) HUP9601541A3 (no)
IL (1) IL118485A (no)
IS (1) IS1913B (no)
LV (1) LV11620B (no)
MA (1) MA23893A1 (no)
MX (1) MX9709897A (no)
MY (1) MY116527A (no)
NO (1) NO306256B1 (no)
NZ (1) NZ286734A (no)
OA (1) OA10458A (no)
PL (1) PL184195B1 (no)
PT (1) PT837860E (no)
RO (1) RO115881B1 (no)
RU (1) RU2161158C2 (no)
SA (1) SA96170065B1 (no)
SG (1) SG54341A1 (no)
SI (1) SI9600186A (no)
SK (1) SK282167B6 (no)
TN (1) TNSN96083A1 (no)
TR (1) TR199600482A1 (no)
TW (1) TW460469B (no)
WO (1) WO1996039408A1 (no)
YU (1) YU49346B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792938B1 (fr) * 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
EP1380585B1 (en) * 1999-04-30 2004-11-10 Pfizer Products Inc. Pyrazolopyridinone as intermediate
US6326495B2 (en) * 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
AU777012B2 (en) 1999-08-21 2004-09-30 Takeda Gmbh Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
US6555572B2 (en) 2000-03-16 2003-04-29 Inflazyme Pharmaceuticals Ltd. Benzylated PDE4 inhibitors
MXPA03010791A (es) * 2001-05-25 2004-03-02 Boehringer Ingelheim Pharma Combinacion de inhibidor de pde4 y tiotropio a sus derivados para tratamiento de enfermedades obstructivas de vias respiratorias y de otras enfermedades inflamatorias.
PA8546001A1 (es) * 2001-05-25 2003-12-30 Pfizer Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias
GB0122031D0 (en) * 2001-09-12 2001-10-31 Pfizer Ltd Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
US20050107420A1 (en) * 2002-05-23 2005-05-19 Boehringe Ingelheim Pharma Gmbh & Co. Kg Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
WO2006075748A1 (ja) * 2005-01-17 2006-07-20 Santen Pharmaceutical Co., Ltd. アレルギー性結膜疾患治療剤
WO2006135627A2 (en) * 2005-06-10 2006-12-21 Merck & Co., Inc. Inhibitors of akt activity
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
ES2378281T3 (es) 2006-07-05 2012-04-10 Nycomed Gmbh Combinación de atorvastatina con un inhibidor de fosfodiesterasa 4 para el tratamiento de neumopatías inflamatorias
EP2350084B1 (en) * 2008-10-17 2015-06-24 Boehringer Ingelheim International GmbH Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor
JP5730896B2 (ja) * 2009-12-04 2015-06-10 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ トリシクロピラゾール誘導体
WO2013084182A1 (en) 2011-12-08 2013-06-13 Glenmark Pharmaceuticals S.A. Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697532A (en) * 1970-08-12 1972-10-10 Squibb & Sons Inc 5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
SU1048746A1 (ru) * 1982-01-29 1987-12-30 Институт физико-органической химии и углехимии АН УССР Гидробромид 8-адамантил-1,з-диметилимидазо 4,5-с имидазо 1,2-а пиридин-2-она,обладающий спазмолитическим действием
FR2579208B1 (fr) * 1985-03-22 1987-05-07 Sanofi Sa Nouveaux derives de le 5-h pyrido (3', 4' : 4,5) pyrrolo (3,2-c) pyridine, leur procede de preparation et leur activite antitumorale
US4940715A (en) * 1988-05-17 1990-07-10 Kissei Pharmaceutical Co., Ltd. 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
BR9406946A (pt) * 1993-07-06 1996-08-06 Pfizer Tetra-hidro-pirazolpiridinas bicíclicas
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives

Also Published As

Publication number Publication date
WO1996039408A1 (en) 1996-12-12
DK0837860T3 (da) 2002-05-27
SI9600186A (en) 1997-04-30
BR9602627A (pt) 1998-09-01
CZ287251B6 (en) 2000-10-11
HUP9601541A2 (en) 1997-02-28
BG100640A (bg) 1997-03-31
AR002745A1 (es) 1998-04-29
KR100191972B1 (ko) 1999-06-15
SK71896A3 (en) 1997-05-07
PL184195B1 (pl) 2002-09-30
CZ162696A3 (en) 1997-01-15
FI114097B (fi) 2004-08-13
DE69525978D1 (de) 2002-04-25
TW460469B (en) 2001-10-21
CA2223624C (en) 2001-02-20
RU2161158C2 (ru) 2000-12-27
SG54341A1 (en) 1998-11-16
AP9600806A0 (en) 1996-07-31
HU9601541D0 (en) 1996-07-29
ES2172583T3 (es) 2002-10-01
TR199600482A1 (tr) 1997-03-21
DZ2044A1 (fr) 2002-07-21
TNSN96083A1 (fr) 2005-03-15
IL118485A (en) 2000-02-17
HRP960268A2 (en) 1997-08-31
NZ286734A (en) 1998-02-26
BG62568B1 (bg) 2000-02-29
AP609A (en) 1997-09-03
PL314459A1 (en) 1996-12-09
PT837860E (pt) 2002-07-31
SA96170065B1 (ar) 2005-12-21
FI974434A0 (fi) 1997-12-05
JPH10510242A (ja) 1998-10-06
EP0837860B1 (en) 2002-03-20
IS4350A (is) 1996-12-07
RO115881B1 (ro) 2000-07-28
MA23893A1 (fr) 1996-12-31
CN1142499A (zh) 1997-02-12
CA2223624A1 (en) 1996-12-12
SK282167B6 (sk) 2001-11-06
JP3107827B2 (ja) 2000-11-13
LV11620B (en) 1997-04-20
MX9709897A (es) 1998-03-31
KR100225719B1 (en) 1999-10-15
IS1913B (is) 2004-02-03
LV11620A (lv) 1996-12-20
CN1061044C (zh) 2001-01-24
YU34696A (sh) 1999-07-28
YU49346B (sh) 2005-07-19
OA10458A (en) 2002-03-27
ATE214700T1 (de) 2002-04-15
FI974434L (fi) 1997-12-05
KR970003440A (ko) 1997-01-28
HUP9601541A3 (en) 1997-05-28
EP0837860A1 (en) 1998-04-29
AU5477396A (en) 1996-12-19
NO306256B1 (no) 1999-10-11
NO962320D0 (no) 1996-06-05
HRP960268B1 (en) 2002-12-31
DE69525978T2 (de) 2002-12-19
US6004974A (en) 1999-12-21
IL118485A0 (en) 1996-09-12
MY116527A (en) 2004-02-28
CO4700460A1 (es) 1998-12-29
AU694871B2 (en) 1998-07-30

Similar Documents

Publication Publication Date Title
DE59409351D1 (de) Pyrrolo[3,4-c]pyrrole
NO974595D0 (no) Imidazo£1,2-a|pyridin-derivater
ZA942571B (en) 1,5 benzodiazepine derivatives
MX9202838A (es) Imidazo[1,5-a]quinoxalinas.
BR9612126A (pt) Derivados de benzazepina
DE69529777D1 (de) 2-Benzylthio-8-amino(1,2,4)triazolo(1,5-a)pyridine
NO962320L (no) Tricykliske 5,6-dihydro-9H-pyrazolo [3,4cÅ-1,2,4-triazolo [4,3-aÅ pyridiner
LV12207A (lv) Tricikliski savienojumi
DE19605177B4 (de) Diebstahlsicherung
AP9400657A0 (en) 1,5 benzodiazepine derivatives
AP9500731A0 (en) 1,5 benzodiazepine derivatives
ID22131A (id) Turunan-turunan 1,2,3,4-tetrahidro-benzofuran [3,2-c] piridin
NO982843L (no) 2,7-Substituerte oktahydro-pyrrol£1,2-a|pyrazin-derivater
GB2311779B (en) 2,3 benzodiazepine derivatives
NO980788D0 (no) Immunosuppressant
DE59607886D1 (de) Wegfahrsperre
EP0745086A4 (en) TRICYCLIC SPIROPIPERIDINE
DE69014784D1 (de) Antivirale Tetrahydroimidazo[1,4]benzodiazepine.
FI950215A0 (fi) Trisykliset kefeemisulfonit
GB9521660D0 (en) Polycyclic dyes
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
ZA94382B (en) Tricyclic 1,2,4-triazolo compounds
KR970032045U (ko) 차량의 편의 장치
CA78660S (en) Tartan
KR960030975U (ko) 차량용 발받침대